Skip to main content
SpringerLink
Log in

Cancer immunotherapy with interleukin-2-activated natural killer cells

  • Protocol
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Natural killer (NK) cells are a subset of lymphocytes with a distinct morphologic appearance (large granular lymphocytes [LGL]) and the ability to kill virally infected and tumor targets but to spare most normal cells. NK cells respond to a variety of biologic agents, such as interleukin-2 (IL-2), or interferons, by upregulation of cytolytic, secretory, and proliferative functions. In cancer-bearing hosts, NK cells have been considered to be the major component of antitumor immunity responsible for rapid elimination of malignant cells from the blood. More recently, however, studies have demonstrated the ability of adoptively transferred, IL-2-activated NK cells to selectively localize into solid tumors tissue and to eliminate established tumors. While these findings indicate a role for NK cells in cancer immunotherapy, additional studies are needed in both animal models and in humans to optimize clinical protocols of cancer therapy based on these cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Whiteside, T. L., Vujanovic, N. L., and Herberman, R. B. (1997) Natural killer cells and tumor therapy, in Current Topics in Microbiology and Immunology 230 (Karre, K. and Colonna, M., eds.), Springer, Heidelberg, Germany, pp. 221–244.

    Google Scholar 

  2. Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L., and Yokoyama, W. M. (2000) In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97, 2731–2736.

    Article  PubMed  CAS  Google Scholar 

  3. Vujanovic, N. L., Nagashima, S., Herberman, R. B., and Whiteside, T. L. (1996) Nonsecretory apoptotic killing by human NK cells. J. Immunol. 157, 1117–1126.

    PubMed  CAS  Google Scholar 

  4. Schwarz, R. E., Vujanovic, N. L., and Hiserodt, J. C. (1989) Enhanced antimetastic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res. 49, 1441–1446.

    PubMed  CAS  Google Scholar 

  5. Vujanovic, N. L., Rabinowich, H., Lee, Y. J., Jost, L., Herberman, R. B., and Whiteside, T. L. (1993) Characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell Immunol. 151, 133–157.

    Article  PubMed  Google Scholar 

  6. Lister, J., Ryoka, W. B., Donnenberg, A. D., et al. (1995) Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with A-NK cells in the immediate post-transplant period. Clin Cancer Res. 1, 607–614.

    PubMed  CAS  Google Scholar 

  7. Yasumura, S., Lin, W-c., Hirabayashi, H., Vujanovic, N. L., Herberman, R. B., and Whiteside, T. L. (1994) Immunotherapy of liver metastases of human gastric carcinoma with IL-2 activated natural killer cells. Cancer Res. 54, 3808–3816.

    PubMed  CAS  Google Scholar 

  8. Basse, P., Herberman, R. B., Nannmark, U., Johansson, E. R., Hokland, M., Wasserman, K., and Goldfarb, R. (1991) Accumulation of adoptively transferred A-LAK cells in metastases. J. Exp. Med. 174, 479–488.

    Article  PubMed  CAS  Google Scholar 

  9. Whiteside, T. L. (1997) Isolation of human NK cells and generation of LAK activity, in Current Protocols in Immunology (Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevack, E. M., and Warren, S., eds.), Wiley, vol. 2, unit 7. 7.

  10. Gunji, Y., Vujanovic, N. L., Hiserodt, J. C., Herberman, R. B., and Gorelik, E. (1989) Generation and characterization of purified adherent lymphokine-activated killer cells in mice. Immunol. 142, 1748–1754.

    CAS  Google Scholar 

  11. Whiteside, T. L. (1997) Measurement of cytotoxic activity of NK/LAK cells, in Current Protocols in Immunology (Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevack, E. M., and Warren, S., eds.), Wiley, vol. 2, unit 7. 18.

  12. Okada, K., Nannmark, U., Vujanovic, N. L., Watkins, S., Basse, P., Herberman, R. B., and Whiteside, T. L. (1996) Elimination of established liver metastasis by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer. Cancer Res. 56, 1599–1608.

    PubMed  CAS  Google Scholar 

  13. Basse, P. H., Herberman, R. B., Hokland, M. E., and Goldfarb, R. H. (1992) Tissue Distribution of Adoptively Transferred Adherent Lymphokine-Activated Killer Cells: Role of Route of Administration. Natl. Immunity and Cell Growth Reg. 11, 193–202.

    CAS  Google Scholar 

  14. Basse, P., Hokland, P., Heron, I., and Hokland, M. (1988) Fate of left ventricular injected cancer cells in Balb/c mice: role of NK cells. JNCI. 80, 657–665.

    Article  PubMed  CAS  Google Scholar 

  15. Nannmark, U., Johansson, B. R., Bryant, J. L., Unger, M. L., Hokland, M. E., Goldfarb, R. H., and Basse, P. (1995) Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res. 55, 4627–4632.

    PubMed  CAS  Google Scholar 

  16. Dethlefsen, L. A., Prewitt, J. M. S., and Mendelson, M. L. (1968) Analysis of tumor growth curves. JNCI. 40, 389–405.

    PubMed  CAS  Google Scholar 

  17. Melder, R. J., Walker, E., Herberman, R. B., and Whiteside, T. L. (1991) Adhesion characteristics of human interleukin-2-activated natural killer cells. Cellular Immunol. 132, 17–192.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biomedical Science Tower, University of Pittsburgh Cancer Institute, W939, 200 Lothrop Street, 15213, Pittsburgh, PA

    Per H. Basse M. D., Ph.D., D.M.Sc. (Assistant Professor)

Authors
  1. Per H. Basse M. D., Ph.D., D.M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theresa L. Whiteside
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald B. Herberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Per H. Basse M. D., Ph.D., D.M.Sc..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basse, P.H., Whiteside, T.L. & Herberman, R.B. Cancer immunotherapy with interleukin-2-activated natural killer cells. Mol Biotechnol 21, 161–170 (2002). https://doi.org/10.1385/MB:21:2:161

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/MB:21:2:161

Index Entries

Search

Navigation